Transplant; Failure, Heart Clinical Trials
2 recruiting trials for Transplant; Failure, Heart. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Transplant; Failure, Heart clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by XVIVO Perfusion (1), Baylor Research Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Assist Transport (XHAT) (device, 1 trial).
Track Transplant; Failure, Heart trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
The purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and...
The Hepatitis C Transplant Collaborative
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Transplant; Failure, Heart, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Transplant; Failure, Heart, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Transplant; Failure, Heart, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.